Yusuke Sonehara
Plus aucun poste en cours
Profil
Yusuke Sonehara worked as a Principal at Mochida Pharmaceutical Co., Ltd., a Senior Manager at Amgen KK, and a Senior Manager-Clinical Development at Solasia Pharma KK.
He received his undergraduate and graduate degrees from Tokyo University of Science.
Anciens postes connus de Yusuke Sonehara
| Sociétés | Poste | Fin |
|---|---|---|
Amgen KK
 Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Corporate Officer/Principal | - |
| MOCHIDA PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | - |
| SOLASIA PHARMA K.K. | Corporate Officer/Principal | - |
Formation de Yusuke Sonehara
| Tokyo University of Science | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SOLASIA PHARMA K.K. | Health Technology |
| MOCHIDA PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Health Technology |
